Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Omecamtiv mecarbil was tested in a 13 week oral gavage study in rats and dogs and in a 26 week and 39 week oral study in rats and dog

Key value for chemical safety assessment

Toxic effect type:
dose-dependent

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
NOAEL
1.5 mg/kg bw/day
Study duration:
subchronic
Species:
dog
Organ:
adrenal glands
heart
liver

Additional information

Justification for classification or non-classification

In a 13 week oral gavage study the NOAEL with rats was 5 mg/kg/day and the NOEL with dogs was 1.5 mg/Kg/day.

In a 26 week and 39 week oral study in rats and dogs, respectively, the NOAEL was 5 mg/kg/day.

Adverse effects occured in the heart and kidney in repeat-dose studies, and effects were also observed in the adrenals which may have been secondary to stress.

Target organs: heart, liver and adrenal gland.